Percent free PSA has emerged as perhaps the most clinically useful of the molecular forms of PSA, with the potential to improve early detection, staging, and monitoring of prostate cancer. Our experts explain when to use this valuable test and how to interpret the information it provides.
|Original language||English (US)|
|Number of pages||15|
|State||Published - Dec 1 2000|
ASJC Scopus subject areas
- Leadership and Management